- Article metrics
- Last updated: Sat, 21 Feb 2026 15:43:46 Z
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Access & Citations
-
- 66k
- Article Accesses
-
- 752
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 94 tweeters
- 4 blogs
- 4 Facebook pages
- 77 news outlets
- 3 Wikipedia page
- 1360 Mendeley
This article is in the 99th percentile (ranked 1,001st) of the 471,040 tracked articles of a similar age in all journals and the 97th percentile (ranked 1st) of the 37 tracked articles of a similar age in Nature Reviews Neurology
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
FDA Issues Precision Genomic Drug Guidance
Science and Enterprise -
Preclinical Test Advances Synthetic Bio ALS Treatment
Science and Enterprise -
Start-Up Designs RNA Drugs on Demand, Raises $40M
Science and Enterprise -
Biotech Start-Up to Discover Cystic Fibrosis Therapy
Science and Enterprise
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.